ASX 200
Start Free Trial

Checkout Our Recommendation for free - 7 days free trial

Subscribe Now
Varun Ratra

Varun Ratra

Varun Ratra is the Managing Director and CEO of Veye, one of Australia's leading independent ASX equities research firms. With over 10 years of financial market experience, Varun brings a wealth of expertise in investment research, stock market analysis, and content strategy to the editorial process. He is dedicated to high-level quality assurance, ensuring every piece of analysis is accurate, authoritative, and accessible for everyday investors. Under his leadership, Veye has become a trusted source for informed decision-making in the ASX landscape. Varun is passionate about demystifying financial markets and remains committed to delivering exceptional value and clarity to every reader.

99
Articles

Articles by Varun Ratra

ASX biotech stock Mesoblast presents growing revenues other catalysts for a potential pull back

ASX biotech stock Mesoblast presents growing reven..

Published on: 12-05-2026
Mesoblast is gaining momentum with rising Ryoncil ..
Read More
After a strong run does BHP still command a buying position?

After a strong run does BHP still command a buying..

Published on: 12-05-2026
BHP reported strong FY26 operational performance w..
Read More
Best ASX stocks in momentum to buy in 2026

Best ASX stocks in momentum to buy in 2026

Published on: 12-05-2026
Discover the best ASX momentum stocks to watch in ..
Read More
Woodside Energy Group, advancing growth and delivering reliable energy

Woodside Energy Group, advancing growth and delive..

Published on: 12-05-2026
Woodside Energy advanced LNG, ammonia and oil proj..
Read More
Oil Prices jump after failure of US-Iran peace talks

Oil Prices jump after failure of US-Iran peace tal..

Published on: 12-05-2026
Oil prices surged after US-Iran peace talks failed..
Read More
3 ASX healthcare stocks to buy while they are down

3 ASX healthcare stocks to buy while they are down

Published on: 12-05-2026
Discover 3 promising ASX healthcare stocks trading..
Read More
CSL’s reduced guidance, impairment, weigh heavy on stock price

CSL’s reduced guidance, impairment, weigh heavy ..

Published on: 11-05-2026
CSL (ASX: CSL) cuts FY26 guidance and flags $5B im..
Read More
Wise Tech Global: FY26 Guidance Holds Firm amid accelerating AI Transformation

Wise Tech Global: FY26 Guidance Holds Firm amid ac..

Published on: 08-05-2026
WiseTech Global (ASX: WTC) holds FY26 guidance fir..
Read More
CXO (Core Lithium) receives around A$157 million (net of costs) in new funding

CXO (Core Lithium) receives around A$157 million (..

Published on: 08-05-2026
Core Lithium (ASX: CXO) secures A$157M in new fund..
Read More
Top ASX Gainers to Watch

Top ASX Gainers to Watch

Published on: 08-05-2026
Top ASX gainers to watch today: Light & Wonder, Re..
Read More
3 ASX Tech stocks to buy

3 ASX Tech stocks to buy

Published on: 08-05-2026
3 ASX tech stocks to buy now: Hansen, Life360 and ..
Read More
Top ASX dividend stocks to have in your portfolio

Top ASX dividend stocks to have in your portfolio

Published on: 07-05-2026
Top ASX dividend stocks including APA, MMS and Tel..
Read More
Showing 1 to 3 of 3 entries

Checkout Our Recommendation for free - 7 days free trial

Start Free Trial

DIVIDEND STOCKS REPORT

Each week we cover companies offering a good combination of growth & dividends, maintaining a balance between stable cash flow and riskier raising stars. Our guidance helps you choose companies with regular dividends and opportunities for lower-risk capital growth.

  • Receive a weekly report on dividend stocks
  • Get insights on companies with stable cash flow
  • Balance between growth and dividends
  • Lower-risk capital growth opportunities
Subscribe Now